Publications

emergence of carbapenem-resistant non-baumannii species of acinetobacter harboring a blaoxa-51-like gene that is intrinsic to a. baumannii.	the bla(oxa-51)-like gene, originally intrinsic to acinetobacter baumannii, had been detected in two clones of acinetobacter nosocomialis and one clone of acinetobacter genomic species "close to 13tu." these bla(oxa-51)-like genes, all preceded by isaba1, were located on plasmids that might have originated with a. baumannii. the plasmid-borne isaba1--bla(oxa-51)-like confers a high level of carbapenem resistance and affects the accuracy of using bla(oxa-51)-like detection as a tool for different ...	2011	22083478
clinical characteristics and prognostic factors of acinetobacter nosocomialis bacteraemia in patients with solid tumours.	the clinical characteristics and risk factors for 28-day mortality in 120 patients with solid tumours with acinetobacter nosocomialis bacteraemia were retrospectively analysed. eighty-one patients (67.5%) had advanced-stage cancer. most of the bacteraemia (37.5%) did not have an identified source. the bacteraemia episodes developed at a median of 15 days after hospitalization, and most during a non-neutropenic period (97.5%). although only half of the patients received appropriate antimicrobial ...	2012	22712825
evaluation of the effect of appropriate antimicrobial therapy on mortality associated with acinetobacter nosocomialis bacteraemia.	appropriate antimicrobial therapy is effective for severe infections caused by acinetobacter baumannii, but efficacy for other acinetobacter species remains to be established. the current study was designed to determine whether appropriate antimicrobial therapy reduces the mortality of patients with acinetobacter nosocomialis bacteraemia. a 9-year retrospective study of 266 patients with monomicrobial a. nosocomialis bacteraemia was conducted at a large teaching hospital in taiwan. multivariable ...	2013	22776466
risk factors and clinical outcome of sulbactam nonsusceptibility in monomicrobial acinetobacter nosocomialis bacteremia.	sulbactam is an effective antimicrobial agent against multidrug-resistant acinetobacter spp. this retrospective study evaluated the risk factors of sulbactam nonsusceptibility (sns) in monomicrobial acinetobacter nosocomialis bacteremia and its related outcome.	2016	25081987
molecular epidemiology of carbapenem non-susceptible acinetobacter nosocomialis in a medical center in taiwan.	the mechanism by which carbapenem non-susceptible acinetobacter nosocomialis (cnsan) is disseminated is rarely described in the literature. in this study, we delineated the molecular epidemiology of cnsan isolated from patients in a medical center in taiwan. fifty-four non-duplicate bloodstream isolates of cnsan were collected at the taipei veterans general hospital between 2001 and 2007. pulsed-field gel electrophoresis (pfge) was performed to determine their clonal relationship. carbapenem-res ...	2015	25724091
comparison between bacteremia caused by acinetobacter pittii and acinetobacter nosocomialis.	patients with acinetobacter pittii and acinetobacter nosocomialis bacteremia have lower mortality rates than those with acinetobacter baumannii bacteremia. however, it is unknown whether these organisms differ in outcomes of bacteremic patients. we conducted this study to answer this question.	2017	25735795